October 17, 2022

Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.

June 6, 2022

The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.

Carl Fichtenbaum, a professor in the Division of Infectious Diseases at the University of Cincinnati College of Medicine and one of the leaders in UC’s efforts to combat COVID-19, is still going to protest marches as his passion for social justice, personally and profession- ally, burns as brightly as ever.

January 24, 2022

Decision Day marks the moment when thousands of incoming Bearcats learn they’ve been accepted to the University of Cincinnati. University officials surprised four area high school seniors at their schools and homes, making them among the first to be accepted into UC in 2022.

October 6, 2022

The University of Cincinnati is committing $12 million to grow inclusive excellence by leveraging diverse perspectives to advance innovation, creativity and complex problem solving in biomedical research. The new program, FIRST+ Lives Here for Urban Health, aligns with the National Institutes of Health’s FIRST (Faculty Institutional Recruitment for Sustainable Transformation) Program and advances the university’s Next Lives Here strategic direction.

September 11, 2023

UC physician-scientist Jordan Kharofa, MD, is leading a clinical trial to improve treatment outcomes for anal cancer patients. The effort has received support from Ride Cincinnati, a important backer of the University of Cincinnati Cancer Center.

February 7, 2023

The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.

November 17, 2022

According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.

April 12, 2022

The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.

April 16, 2021

Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.